Shishijimicin A: structure in first source
ID Source | ID |
---|---|
PubMed CID | 21577974 |
MeSH ID | M0447795 |
Synonym |
---|
shishijimicin a |
HY-N10537 |
CS-0610687 |
503860-50-2 |
Shishijimicin A is a scarce marine natural product with highly potent cytotoxicities. It is a potential payload or a lead compound for designed antibody-drug conjugates.
Excerpt | Reference | Relevance |
---|---|---|
"Shishijimicin A is a scarce marine natural product with highly potent cytotoxicities, making it a potential payload or a lead compound for designed antibody-drug conjugates. " | ( Streamlined Total Synthesis of Shishijimicin A and Its Application to the Design, Synthesis, and Biological Evaluation of Analogues thereof and Practical Syntheses of PhthNSSMe and Related Sulfenylating Reagents. Alemany, LB; Aujay, M; Gavrilyuk, J; Lee, C; Li, R; Lu, Z; Nicolaou, KC; Pitsinos, EN; Sandoval, J, 2018) | 2.21 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.43) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (14.29%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |